New research shows how early cancer screening and surveillance in patients with Li-Fraumeni syndrome (LFS) results in additional years of life, and is cost effective for third-party payers.
Cost effectiveness of early cancer surveillance
Brabus Launches ‘Deep Blue’ G-Wagon, Speedboat & Luxury Watch Line
Brabus is unifying its collaborations with Mercedes-AMG, Finland’s Axopar Boats, and Panerai luxury watches under one Deep Blue collection.Being that Brabus is...
